60 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33930649 | A green tea extract and epigallocatechin-3-gallate attenuate the deleterious effects of irinotecan in an oral epithelial cell model. | 2021 Jun | 1 |
2 | 32198390 | Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway. | 2020 Mar 20 | 1 |
3 | 33122740 | Protective effect of epigallocatechin-3-gallate (EGCG) on toxic metalloproteinases-mediated skin damage induced by Scyphozoan jellyfish envenomation. | 2020 Oct 29 | 1 |
4 | 30854739 | Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes. | 2019 Jul | 1 |
5 | 29342922 | Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity? | 2018 Jan 15 | 3 |
6 | 29552308 | EGCG inhibited bladder cancer T24 and 5637 cell proliferation and migration via PI3K/AKT pathway. | 2018 Feb 23 | 1 |
7 | 30135355 | Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In Vitro. | 2018 Aug 22 | 1 |
8 | 30563268 | Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer. | 2018 Dec 6 | 2 |
9 | 28040581 | EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9. | 2017 Mar | 3 |
10 | 28098879 | Cytokines, inducers and inhibitors modulate MMP-2 and MMP‑9 secretion by human Fanconi anemia immortalized fibroblasts. | 2017 Mar | 1 |
11 | 28112361 | Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells. | 2017 Mar | 1 |
12 | 28440509 | Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells. | 2017 Jun | 1 |
13 | 27073430 | Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9. | 2016 Apr | 3 |
14 | 27231728 | Comparative effects of selected plant polyphenols, gallic acid and epigallocatechin gallate, on matrix metalloproteinases activity in multidrug resistant MCF7/DOX breast cancer cells. | 2016 | 3 |
15 | 27668533 | Inhibition of MMP-9 by green tea catechins and prediction of their interaction by molecular docking analysis. | 2016 Dec | 4 |
16 | 27774417 | Green tea catechin inhibits the activity and neutrophil release of Matrix Metalloproteinase-9. | 2016 Oct | 11 |
17 | 27832636 | Inhibition of EMMPRIN and MMP-9 Expression by Epigallocatechin-3-Gallate through 67-kDa Laminin Receptor in PMA-Induced Macrophages. | 2016 | 9 |
18 | 24481780 | Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells. | 2015 Jun | 3 |
19 | 25832428 | The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway. | 2015 Apr | 1 |
20 | 24190483 | In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors. | 2014 Jan | 1 |
21 | 24338484 | Epigallocatechin-3-gallate induces apoptosis, inhibits proliferation and decreases invasion of glioma cell. | 2014 Feb | 1 |
22 | 24606444 | Epigallocatechin-3-gallate inhibits tax-dependent activation of nuclear factor kappa B and of matrix metalloproteinase 9 in human T-cell lymphotropic virus-1 positive leukemia cells. | 2014 | 2 |
23 | 24721612 | Galloyl moieties enhance the dentin biomodification potential of plant-derived catechins. | 2014 Jul | 1 |
24 | 24971028 | Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells. | 2014 | 2 |
25 | 25479224 | The effect of Epigallocatechin-3-gallate in allergic airway inflammation. | 2014 Dec | 2 |
26 | 23835612 | (-)-Epigallocatechin-3-gallate blocks nicotine-induced matrix metalloproteinase-9 expression and invasiveness via suppression of NF-κB and AP-1 in endothelial cells. | 2013 Sep | 5 |
27 | 23863984 | Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells. | 2013 Oct | 1 |
28 | 24085323 | In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors. | 2013 Dec | 1 |
29 | 24179522 | Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression. | 2013 Nov | 2 |
30 | 24353864 | Effect of Epigallocatechin-3-Gallate on PMA-Induced MUC5B Expression in Human Airway Epithelial Cells. | 2013 Dec | 2 |
31 | 22101170 | Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro. | 2012 Jan | 1 |
32 | 22280355 | Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. | 2012 Feb | 2 |
33 | 22707304 | EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells. | 2012 Dec | 1 |
34 | 22941057 | Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-κB‑mediated matrix metalloproteinase-9 expression. | 2012 Nov | 3 |
35 | 23167425 | (-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells. | 2012 | 1 |
36 | 20446926 | (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. | 2011 Apr | 1 |
37 | 21170718 | Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process. | 2011 Sep | 4 |
38 | 21388137 | Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells. | 2011 Apr 27 | 1 |
39 | 21821246 | Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. | 2011 Oct | 1 |
40 | 20043125 | (-)-Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells. | 2010 Feb | 1 |
41 | 20527725 | Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. | 2010 Jul | 12 |
42 | 20664983 | Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines. | 2010 Sep | 2 |
43 | 19885578 | Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines. | 2009 Dec | 1 |
44 | 18632202 | (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. | 2008 Nov 18 | 1 |
45 | 18665171 | Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. | 2008 Aug 19 | 1 |
46 | 19137815 | [Growth inhibition of prostate cancer cells by epigallocatechin-3-gallate in the presence of Zn2+ in vitro]. | 2008 Dec | 1 |
47 | 16862172 | Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. | 2007 Feb 1 | 1 |
48 | 17081606 | Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg. | 2007 Sep | 1 |
49 | 17382921 | Matrix proteases, green tea, and St. John's wort: biomedical research catches up with folk medicine. | 2007 May | 1 |
50 | 17944751 | Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. | 2007 Nov | 2 |